300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 45 Biotech VC Funds & Investors in Hong Kong (October 2023)

The most active venture capital funds investing in Hong Kong Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Hong Kong Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Loyal VC
VC Fund
3 United States, Canada, United Kingdom Pre-Seed, Seed Software, Artificial Intelligence, E-Commerce $78k–$2.5M
Arkansas Development Finance Authority
VC Fund
2 United States, Hong Kong Seed, Pre-Seed Medical, Biotechnology, Fashion
CPT Capital
VC Fund
2 United States, Israel, United Kingdom Series A, Seed, Series B Food and Beverage, Food Processing, Biotechnology $1.2M–$226M
Lever VC
VC Fund
2 United States, China, Brazil Seed, Series A, Pre-Seed Food and Beverage, Food Processing, Biotechnology $500k–$24M
Gobi Partners GBA
VC Fund
2 Hong Kong, China Seed, Angel, Series A Biotechnology, Medical, Hospitality
Bold Capital Partners
VC Fund
2 United States, Hong Kong, Canada Series A, Seed, Series B Health Care, Software, Biotechnology $2M–$50M
Whist Subholdings
VC Fund
2 Hong Kong Seed Medical, Agriculture, Biotechnology
FHB Ventures
VC Fund
2 Hong Kong, United States Seed, Series A, Series B Medical, Agriculture, Biotechnology
Artesian VC
VC Fund
2 Australia, United States, Hong Kong Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $70k–$12M
Simmons Foods
VC Fund
2 Hong Kong Seed Medical, Agriculture, Biotechnology
PT Medion
VC Fund
2 Hong Kong Seed Medical, Agriculture, Biotechnology
Coent Venture Partners
VC Fund
1 Taiwan, China, Hong Kong Seed, Series A Apps, SaaS, Travel $275k–$800k
Beyond Ventures
VC Fund
1 Hong Kong, China, Canada Seed, Series A Artificial Intelligence, Information Technology, Health Care
Innovation and Technology Venture Fund
VC Fund
1 Hong Kong, China Series A, Seed, Series B Information Technology, Logistics, Financial Services $2.5M–$14M
S2G Ventures
VC Fund
1 United States, Canada, Israel Series A, Series B, Seed Food and Beverage, Agriculture, Biotechnology $250k–$89M
Alon Capital Ltd
VC Fund
1 Hong Kong Series A Biopharma, Life Science, Biotechnology
Thia Ventures
VC Fund
1 United States, France, Denmark Series A, Seed, Pre-Seed Biotechnology, Health Care, Life Science $3.1M–$20M
WuXi AppTec
VC Fund
1 United States, China, Israel Series A, Series B, Series C Biotechnology, Pharmaceutical, Health Care $5.9M–$100M
LongeVC
VC Fund
1 Hong Kong, Switzerland, United States Seed, Series A Health Care, Biotechnology, Therapeutics
Good Startup
VC Fund
1 United States, France, Israel Seed, Series A, Pre-Seed Biotechnology, Food and Beverage, Retail $1.9M–$8.4M
Vectr
VC Fund
1 United States, Hong Kong, Singapore Seed, Series A, Pre-Seed FinTech, Artificial Intelligence, Financial Services $425k–$35M
Tiger Jade Capital
VC Fund
1 Hong Kong Series A Biopharma, Life Science, Biotechnology
Pavilion Capital
VC Fund
1 United States, Japan, Indonesia Series B, Series A, Series C Biotechnology, Health Care, Information Technology $2M–$1.1B
Juvenescence
VC Fund
1 United States, Hong Kong, Isle of Man Series A, Debt Financing Biotechnology, Pharmaceutical, Health Care $3M–$9M
Proxima Ventures Ltd
VC Fund
1 China, United States, Israel Series A, Series B, Seed Biotechnology, Health Care, Health Diagnostics $206k–$150M
Prox Ventures
VC Fund
1 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care
Emerging Technology Partners
VC Fund
1 China, Hong Kong, United States Series A, Series B Health Care, Biotechnology, Medical $3.4M–$9.6M
The International Medical
VC Fund
1 Hong Kong Seed Medical, Hospitality, Biotechnology
Apis Partners
VC Fund
1 India, Singapore, South Africa Private Equity, Series B Financial Services, Payments, FinTech $5M–$120M
Merrill Lynch
VC Fund
1 United States, India, United Kingdom Series B, Series C Software, Information Technology, Internet $10M–$85M
Ping An
VC Fund
1 China, United States, Japan Series A, Series E Health Care, FinTech, Finance $1.4M–$300M
208 Seed Ventures
VC Fund
1 Hong Kong Seed Biotechnology
Particle Accelerator Limited (ParticleX)
VC Fund
1 Hong Kong, United States, Singapore Seed, Pre-Seed, Series A Artificial Intelligence, Information Technology, Software $1.2M–$5.5M
Human Longevity and Performance Impact Venture Fund
VC Fund
1 Hong Kong Series A Health Care, Biotechnology
ETP Ventures
VC Fund
1 China, Hong Kong Seed, Angel, Series A Health Care, Biotechnology, Medical
Gobi Partners
VC Fund
1 China, Malaysia, Indonesia Series A, Seed, Series B E-Commerce, Financial Services, Internet $687k–$30M
AEF Greater Bay Area Fund
VC Fund
1 Hong Kong Series A, Series B FinTech, Payments, Biopharma
Hillhouse Capital Group
VC Fund
1 China, United States, India Series B, Series A, Series C Biotechnology, Health Care, Software $1.4M–$310M
StartUp Health
VC Fund
1 United States, Canada, United Kingdom Seed, Pre-Seed Health Care, Wellness, Medical $20k–$2.5M
Longevity Vision Fund
VC Fund
1 United States, Hong Kong, Isle of Man Series B, Series C, Seed Biotechnology, Health Care, Medical $35M–$440M
Capital Union Investments
VC Fund
1 Hong Kong, United States Seed, Series A SaaS, Genetics, Software $2M–$10M
Formic Ventures
VC Fund
1 United States, United Kingdom, Hong Kong Seed, Series A Biotechnology, Health Care, Artificial Intelligence $1.3M–$5M
WI Harper Group
VC Fund
1 United States, Taiwan, China Series A, Seed, Series B Software, Health Care, Biotechnology $1.4M–$25M
China Venture Capital
VC Fund
1 China, Hong Kong, United States Angel, Series B, Series A Manufacturing, Biotechnology, Information Technology $412k–$14M
AngelHub
VC Fund
1 Hong Kong, United States, Israel Series A, Seed, Pre-Seed FinTech, Blockchain, Financial Services $1.1M–$4.8M
Access all 45 VC funds in Hong Kong Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Loyal VC
VC Fund · Toronto, Ontario, Canada · 3 investments in Hong Kong Biotech startups, 11 in the past 12 months

Loyal runs a global venture fund with quarterly redemptions and a proprietary gate-stage process, reducing investment bias and unlocking greater returns. Partnered with INSEAD, Founder Institute, and 500+ advisors, we are Loyal to the world with 250+ investments in 50+ countries.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, E-Commerce
  • Stage:Pre-Seed, Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 129
  • Round size: Seed $78k–$2.5M; Pre-Seed $110k–$900k
  • Lead/follow: 14% lead, 86% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • InSyBio — A disruptor to Precision Medicine and Nutrition through biomarker discovery.
  • ZestIOT — ZestIOT is an IoT & AI enabled aviation platform to integrate passenger, baggage, aircraft, ground & airport operations.
  • Wellx — Turn your health into currency. At Wellx, we're focused on making you healthier. Insurance helps us make it happen.
Show all investments...

Arkansas Development Finance Authority
VC Fund · Little Rock, Arkansas, United States · 2 investments in Hong Kong Biotech startups

Welcome to Arkansas Development Finance Authority (ADFA), your source for safe, decent, affordable housing in Arkansas. Contact us at (501) 682-5900 to secure your dream home today!

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Fashion
  • Stage:Seed, Pre-Seed
  • Geography: United States, Hong Kong

Investor stats

  • Total investments: 5
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Ascendant Dx — Choose An Online Slot Game
  • Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
  • BlueOak Resources — BlueOak: Sourcing Metals Sustainably™ from End-of-Life Electronics.BlueOak believes in the philosophy of resource and capital efficiency. They are building distributed mini-refineries that use proven, capital-efficient refining processes towards extracting precious metals and rare earth elements from e-waste. Their vision is to revolutionize howwe treat end of life electronics: converting the e-waste of today into a sustainable source of critical metals and rare earths for the technologies of tomorrow.
Show all investments...

CPT Capital
VC Fund · London, England, United Kingdom · 2 investments in Hong Kong Biotech startups

Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.

Show more...

Investment focus

  • Industry: Food and Beverage, Food Processing, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 47
  • Round size: Seed $1.2M–$20M; Series A $2.5M–$20M; Series B $15M–$226M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • PoLoPo — PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs.
  • Equinom — Equinom is a fully integrated food-tech company, combining agricultural know-how, culinary expertise and deep technology to develop delicious, nutritious, affordable and sustainable non-GMO plant-based ingredients – from the ground up.Sustainable, plant-based proteins are key to feeding Earth’s 10B people by 2050 The plant-based food market grew27% in 2020 and is projected to reach $162B by 2030.The industry is unable to supply the full demand for food vs. feed For decades, crops have been farmed primarily for animal feed – not for human consumption. To be palatable in human food, these crops require extensive and expensive processing. . With limited processing facilities equipped for this use, the industry is on track to supply only 50% of projected demand for plant-based foods.What is Equinom doing about it? Equinom is using science and technology to develop superior ingredients naturally, at the source – in a fraction of the time typically required to breed new crops. Equinom crops are bred naturally, without genetic editing or modification, and are optimized to make meat and dairy analogues more delicious, nutritious, cost-effective and sustainable. Ingredients designed by deep tech to bring out nature’s best The company’s proprietary Manna™ technology platform uses AI to speed the development of superior, high-yield, non-GMO ingredients as nature intended – featuring the quality traits that satisfy consumer expectations. The technology also ensures biodiversity and climate resilience that are critical to ensure food security in light of climate change. What makes Equinom a compelling foodtech investment and collaborator? Working with great partners including Meatless Farm, Roquette with GoodMills Group., Equinom is recognized as a trusted developer and supplier of unrivaled ingredients. Prestigious strategic investors such as BASF and Roquette have helped position Equinom as one of the breakout Round C companies to fuel the worldwide surge in plant-based eating.
  • Liberation Labs — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
Show all investments...

Lever VC
VC Fund · New York, New York, United States · 2 investments in Hong Kong Biotech startups

Lever VC is a U.S.-Hong Kong venture capital fund founded by Managing Partner Nick Cooney and investing in early stage companies in the alternative protein sector (plant-based and “clean”/cell-based meat, egg and dairy companies). Lever VC operates globally, with offices in Hong Kong and the U.S. and staff in the US, Hong Kong, Europe, andIsrael. Entrepreneurs and startups interested in connecting with Lever VC about possible investment can reach the team and submit information about their company at http://www.levervc.com.Managing Partner Nick Cooney is the Co-Founder and former Managing Trustee of New Crop Capital, a private venture capital trust vehicle investing in the alternative protein space, and is Co-Founder of the Good Food Institute, the world’s largest non-governmental organization working to grow the alternative protein space. The General Partners at Lever VC have deployed over $1.5 billion in capital over the past decade across a variety of sectors, including over thirty deals in the alternative protein space.

Show more...

Investment focus

  • Industry: Food and Beverage, Food Processing, Biotechnology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, China, Brazil

Investor stats

  • Total investments: 36
  • Round size: Seed $700k–$4.5M; Pre-Seed $500k–$850k; Series A $1.5M–$24M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • CellX — Creating a sustainable and humane future through cellular agriculture
  • Melt&Marble — Melt&Marble, formerly known as Biopetrolia, was founded patent holding firm for co-founder Professor Jens Nielsen’s research group.
  • Bond Pet Foods — We make vegan and protein-rich pet food and treats formulated by board-certified veterinary nutritionists.
Show all investments...

Gobi Partners GBA
VC Fund · Central and Western, Hong Kong Island, Hong Kong · 2 investments in Hong Kong Biotech startups

Gobi Partners GBA is part of the Pan-Asian venture capital platform Gobi Partners. Gobi GBA is the sole general partner (GP) of the Alibaba Hong Kong Entrepreneurs Fund (AEF) as well as the AEF Greater Bay Area Fund (AEF GBA Fund) and has formed strategic partnerships with other renowned financial institutions such as HSBC and Hang Seng Bank.Gobi GBA has invested in over 70 start-ups across the Greater Bay Area and has fostered the growth of 7 unicorns including Airwallex, Amber, Animoca Brands, GoGoX, Prenetics, and more.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Hospitality
  • Stage:Seed, Angel, Series A
  • Geography: Hong Kong, China

Investor stats

  • Total investments: 3
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Immuno Cure — Immuno Cure, it is a biotechnology company it is specialized in the study and creation of immunotherapies for cancer, inflammatory, and infectious disorders.
  • Guoke Ling Fiber — Guoke Ling Fiber focuses on technological research and industrialization of key materials for hydrogen fuel cells. Guoke offers carbon fiber base paper and carbon paper production lines.
  • BioMed Technology Holdings — BioMed offer a comprehensive service that includes a range of sophisticated tests performed by professionals, together with an interpretation and recommendations for how to live a healthy life.
Show all investments...

Bold Capital Partners
VC Fund · Santa Monica, California, United States · 2 investments in Hong Kong Biotech startups, 8 in the past 12 months

A collection of entrepreneurs, engineers, physicists, doctors, surfers, and musicians who are committed to helping entrepreneurs achieve their dreams of changing the world.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: United States, Hong Kong, Canada

Investor stats

  • Total investments: 88
  • Round size: Seed $2M–$15M; Series A $4M–$40M; Series B $2.5M–$50M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Viome — Test your gut microbiome and measure your health down to the molecular level to get personalized nutrition recommendations and supplements made uniquely for you.
  • Crowdz — Make accounts receivables a thing of the past with a competitive invoice auction for selling your invoices with invoice financing
  • Solarea Bio — Solarea Bio is a biotech company in Cambridge MA building solutions for health disorders using bacteria and fungi native to healthy foods to create powerful synergistic, anti-inflammatory microbial assemblages.
Show all investments...

Whist Subholdings
VC Fund · 2 investments in Hong Kong Biotech startups

Whist Subholdings is a venture capital investment firm.

Show more...

Investment focus

  • Industry: Medical, Agriculture, Biotechnology
  • Stage:Seed
  • Geography: Hong Kong

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Show all investments...

FHB Ventures
VC Fund · 2 investments in Hong Kong Biotech startups

FHB Ventures is a venture capital firm.

Show more...

Investment focus

  • Industry: Medical, Agriculture, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: Hong Kong, United States

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • EarthOptics — EarthOptics is building the cloud-based machine learning platform for soil and ground management.
  • Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Show all investments...

Artesian VC
VC Fund · Melbourne, Victoria, Australia · 2 investments in Hong Kong Biotech startups, 13 in the past 12 months

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Australia, United States, Hong Kong

Investor stats

  • Total investments: 172
  • Round size: Seed $96k–$2.4M; Pre-Seed $70k–$1.5M; Series A $3.3M–$12M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • ZoomAgri — ZOOMAGRI provides an assessment of agricultural commodities to all participants of Agri supply chain via AI, computer vision and IoT.
  • Supplynote — End-to-end supply chain management tool to track inventory, orders, payments and suppliers online
  • Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
Show all investments...

Simmons Foods
VC Fund · Siloam Springs, Arkansas, United States · 2 investments in Hong Kong Biotech startups

Simmons Foods is a leading supplier of poultry, pet and ingredient products based in Siloam Springs, Arkansas.

Show more...

Investment focus

  • Industry: Medical, Agriculture, Biotechnology
  • Stage:Seed
  • Geography: Hong Kong

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
PT Medion
VC Fund · 2 investments in Hong Kong Biotech startups

PT Medion is a venture capital investment firm.

Show more...

Investment focus

  • Industry: Medical, Agriculture, Biotechnology
  • Stage:Seed
  • Geography: Hong Kong

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Show all investments...

Coent Venture Partners
VC Fund · Singapore, Central Region, Singapore · 1 investments in Hong Kong Biotech startups

Coent Venture Partners provides seed and venture-stage funding to brilliant entrepreneurs and companies across all sectors in Asia. The company backed these entrepreneurs and companies with unparalleled support in funding, management, overseas business development, and exposure to their network.

Show more...

Investment focus

  • Industry: Apps, SaaS, Travel
  • Stage:Seed, Series A
  • Geography: Taiwan, China, Hong Kong

Investor stats

  • Total investments: 4
  • Round size: Seed $275k–$800k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • QLL — QLL (Quick Language Learning) Pte. Ltd. is a company specialized in developing language learning apps, they are based in Taiwan and registered in Singapore. 2007, they launched a break-through Chinese learning gadget, “Pocket Chinese Tutor”, it is an Mp4 player with Chinese speech assessment function, it can help learner correct their accent ofspeaking Chinese.
  • Prenetics — CircleDNA is an at-home, non-invasive DNA test providing health insights across 500+ reports based on your unique genetic blueprint.
  • HelloWings — "See" the cheapest fare, year-round and fees included. Customized combination tickets. HelloWings ensures you'll arrive to destination on budget & in style.
Show all investments...

Beyond Ventures
VC Fund · Tsuen Wan, New Territories, Hong Kong · 1 investments in Hong Kong Biotech startups

A US$60M startup fund aiming at revitalizing HK’s ecosystem of innovation by connecting local venture capitalists and entrepreneurs to invest in ideas and startups. It is co-founded by Hony Capital, eGarden Ventures & several successful HK entrepreneur

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Hong Kong, China, Canada

Investor stats

  • Total investments: 16
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • SpacemiT — SpacemiT is a computing chip company developing natively integrated cloud-edge-device architecture. It focuses on building RISC-V high-performance CPUs and providing computing solutions with integrated hardware and software optimization. The company's mission is to be the cornerstone of computing power in the digital age, driven to become asignificant global computing powerhouse.
  • Springdel — Move beyond cloud and legacy MDM with an enterprise-grade EdgeOps platform purpose-built for the interactive Edge of Things.
  • Yuchao Technology — Yuchao Technology is a digital collecting platform that uses blockchain technology to protect intellectual property.
Show all investments...

Innovation and Technology Venture Fund
VC Fund · 1 investments in Hong Kong Biotech startups

The HK$2 billion ITVF was set up by the Hong Kong Government with a view to creating a vibrant local innovation and technology eco-systems

Show more...

Investment focus

  • Industry: Information Technology, Logistics, Financial Services
  • Stage:Series A, Seed, Series B
  • Geography: Hong Kong, China

Investor stats

  • Total investments: 14
  • Round size: Series A $2.5M–$14M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Qupital — Qupital helps e-commerce sellers with our Fintech, bringing them a financing solution that is easier to apply, more efficient and at a lower cost.
  • Jumppoint — Founded in Hong Kong since 2020, Jumppoint developed in house its own multi-layer dynamic routing algorithm, jumppoint.ai, to offer highly efficient yet cost-saving logisitics services to B2B and B2C users, with real-time logisitcs data embeded. Beyond Hong Kong headquarters and R&D centre, Jumppoint also has extensive presence in Asia suchas Kuala Lumpur, Taipei and Southeast Asia headquarters, Singapore, providing localised logsitics services.
  • ICW — ICW is an integrated software-as-a-service quality & product compliance management platform and certification marketplace for retailers and e-commerce companies
Show all investments...

S2G Ventures
VC Fund · Chicago, Illinois, United States · 1 investments in Hong Kong Biotech startups, 15 in the past 12 months

S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.

Show more...

Investment focus

  • Industry: Food and Beverage, Agriculture, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 143
  • Round size: Seed $250k–$27M; Series A $4.3M–$89M; Series B $3.5M–$45M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • MEND — Mend is the scientifically proven way to heal and enhance your body faster.
  • TechMet — TechMet Ltd backs world-class teams and makes direct investments into companies and assets across the value chain.
  • Electric Hydrogen — Electric Hydrogen designs and builds low-cost, high-efficiency green hydrogen systems to economically decarbonize industrial sectors like ammonia and steel
Show all investments...

Alon Capital Ltd
VC Fund · Rosh Ha'ayin, HaMerkaz, Israel · 1 investments in Hong Kong Biotech startups

Make the right startup move by using our startup tools, guides, calculators and templates. Learn from other successful entrepreneurs by reading our case studies

Show more...

Investment focus

  • Industry: Biopharma, Life Science, Biotechnology
  • Stage:Series A
  • Geography: Hong Kong

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Show all investments...

Thia Ventures
VC Fund · Genève, Geneve, Switzerland · 1 investments in Hong Kong Biotech startups

WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Seed, Pre-Seed
  • Geography: United States, France, Denmark

Investor stats

  • Total investments: 12
  • Round size: Seed $3.1M–$20M; Series A $6.1M–$11M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Liberation Labs — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
  • People Science — People Science offers data collection technology and services for clinical research studies of alternative medicines and wellness interventions.
  • Pow.bio — Pow.bio provides fermentation services for synthetic biology.
Show all investments...

WuXi AppTec
VC Fund · Shanghai, Shanghai, China · 1 investments in Hong Kong Biotech startups

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 42
  • Round size: Series A $5.9M–$90M; Series B $6.8M–$100M; Series C $30M–$40M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
  • Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
  • Stemirna — Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, andgenetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients.
Show all investments...

LongeVC
VC Fund · Lugano, Ticino, Switzerland · 1 investments in Hong Kong Biotech startups

With more than 30 portfolio companies across AI, pet health, ageing medicine and more, LongeVC provides venture capital for the biotech and longevity sectors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A
  • Geography: Hong Kong, Switzerland, United States

Investor stats

  • Total investments: 3
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Turn.bio — Turn Biotechnologies is a Stanford spinout developing therapies to effectively return mature differentiated cells to a dramatically younger state leaving their differentiated identity unaltered.​Turn Biotechnologies surpasses traditional approaches based on single gene/pathway manipulations and tackles the multifaceted manifestation ofcellular age at the organ, tissue, and organismal level to extend the healthspan of people. As a result, age is reset by epigenetically reprogramming cells.
  • Deep Longevity — Deep Longevity provides customers with the most efficient, reliable, and useful aging and longevity clocks to address their needs.
  • PreComb Therapeutics — functional precision medicine, oncology, cancer, discovery, organoid, predictive, ai, 3DTwin, data mining, therapy guidance, automated, immune oncology, 2curex, xilis, usz, dkfz, nct, switzerland
Show all investments...

Good Startup
VC Fund · Singapore, Central Region, Singapore · 1 investments in Hong Kong Biotech startups

Good Startup is a venture firm focused on the alternative protein sector.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Retail
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, France, Israel

Investor stats

  • Total investments: 9
  • Round size: Seed $1.9M–$8.4M
  • Lead/follow: 0% lead, 100% follow
  • Last fund: Likely still investing — raised $34M in 2022

Portfolio highlights

  • Novel Farms — Novel Farms uses microbial fermentation to develop cruelty-free, inexpensive and tunable bioscaffolds for the production of cell-based meat products. Novel Farms mission is to craft the taste and texture of the gourmet meats and transform cell-based meat consumption into a sought-after culinary experience for the next generation of consciouseaters.
  • Extracellular — Extracellular is a scale-up and development partner, channelling biology, digitalisation and biomanufacturing expertise to accelerate the potential of cultivated meat.
  • Standing Ovation — Animal-free dairy cheese
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Vectr
VC Fund · Sheung Wan, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Biotech startups, 6 in the past 12 months

Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.

Show more...

Investment focus

  • Industry: FinTech, Artificial Intelligence, Financial Services
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Hong Kong, Singapore

Investor stats

  • Total investments: 72
  • Round size: Seed $425k–$4M; Series A $1M–$35M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
  • Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
  • MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Show all investments...

Tiger Jade Capital
VC Fund · Central and Western, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Biotech startups

Tiger Jade Capital is a Private Equity fund focused on global healthcare industry. It is a comprehensive healthcare fund covering new drugs, CRO, medical equipment, etc.

Show more...

Investment focus

  • Industry: Biopharma, Life Science, Biotechnology
  • Stage:Series A
  • Geography: Hong Kong

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Show all investments...

Pavilion Capital
VC Fund · New York, New York, United States · 1 investments in Hong Kong Biotech startups, 6 in the past 12 months

Provides growth equity to market leading companies in the United States and China

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: United States, Japan, Indonesia

Investor stats

  • Total investments: 70
  • Round size: Series A $2M–$275M; Series B $18M–$412M; Series C $37M–$1.1B
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — raised $50M in 2018

Portfolio highlights

  • Travelio — Temukan akomodasi yang cocok untuk liburan bersama keluarga, sahabat maupun urusan bisnis di www.travelio.com. Lebih luas, lebih nyaman dan lebih seru. Cek www.travelio.com
  • EcoSpirits — The World's first low carbon, low waste spirits distribution technology. Join the revolution. End single use glass.
  • Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
Show all investments...

Juvenescence
VC Fund · Douglas, NA - Isle of Man, Isle of Man · 1 investments in Hong Kong Biotech startups

Juvenescence is extending healthy human lifespan through aging research, development of therapies to counter age-related diseases & our ketone ester drink, Metabolic Switch.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Series A, Debt Financing
  • Geography: United States, Hong Kong, Isle of Man

Investor stats

  • Total investments: 12
  • Round size: Series A $3M–$9M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • LyGenesis — LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD).
  • MDI Therapeutics — MDI Therapeutics is an operator of a discovery stage company focused on developing novel therapies for fibrotic diseases. The company have developed a proprietary discovery platform which has successfully identified novel small molecule and protein drug candidates, and have advanced these programs through key translational experiments usingclinical biomarkers.
  • Souvien Therapeutics — Souvien Therapeutics is a biotechnology company focused on developing therapeutic agents to modulate critical epigenetic mechanisms associated with neurodegeneration.
Show all investments...

Proxima Ventures Ltd
VC Fund · Tel Aviv, Tel Aviv, Israel · 1 investments in Hong Kong Biotech startups

Proxima Ventures is focused on the management of investment portfolios for its customers. It offers them with financial products and consulting services. Proxima Ventures was acquired by Soluto in October 2013. Proxima Ventures was founded by Chaim Venezia and Uri Ra'anan and is based in Tel Aviv, Israel.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Health Diagnostics
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Israel

Investor stats

  • Total investments: 17
  • Round size: Seed $750k–$1.6M; Series A $206k–$10M; Series B $10M–$150M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
  • Yidianling — Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.
  • Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Show all investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 1 investments in Hong Kong Biotech startups

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 46
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
  • VacV Biotech — VacV Biotherapeutics develops an oncolytic virus platform based on the vaccinia virus. The platform genetically modifies the oncolytic virus, which improves its specificity to tumors, reduces neurotoxicity, enhances the therapeutic effect, and greatly increases the production of extracellular enveloped virus (EEV). It has higher safety andefficiency and can be administered by intravenous injection.
  • HROCT LITT Medtech — HROCT LITT Medtech has developed the unique SNP(Smart Needle Probe) needle imaging, assembled as a catheter, which OD is smaller than 1/5 of the traditional invasive OCT catheter, while the depth and resolution are all multiple times of the traditional invasive OCT catheter, achieving 1um level to supply the histopathology needed microimaging.The fiber could be compatible with different kinds of biopsy needles to access the targets, and also could be coupled with a specific laser to achieve OCT situ diagnosis and laser ablation. Its technology provides revolutionary solutions to neurosurgery, interventional pulmonology, neurovascular, nephropathy, mammary gland, cardiac, GI, and other fields.
Show all investments...

Emerging Technology Partners
VC Fund · San Francisco, California, United States · 1 investments in Hong Kong Biotech startups

Founded in 2000, Emerging Technology Partners (“ETP”) is a life sciences focused investment fund with a cross border investment focus. ETP was founded with a simple mission: to provide capital and assist management in building and commercializing breakthrough diagnostic and therapeutic products in the fields of life sciences, while providingsuperior returns to their investors.ETP supports their portfolio companies facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth in both US and China. They have investment partners in San Francisco, Boston, Washington DC, and Beijing.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 7
  • Round size: Series B $3.4M–$9.6M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • Deep Longevity — Deep Longevity provides customers with the most efficient, reliable, and useful aging and longevity clocks to address their needs.
  • Polaris Biology — Polaris Biology is a medical technology company specializing in the development and clinical application of cell-level precision diagnostic technology, is dedicated to exploring and studying individual and dynamic changes in tumors at the cellular level, and using this information to support clinical tumor diagnosis and treatment.
  • Precision Autoimmune Therapeutics — Precision Autoimmune Therapeutics is a clinical-stage innovative drug development company focused on precision therapeutics for patients with autoimmune and inflammatory diseases.
Show all investments...

The International Medical
VC Fund · Yau Tsim Mong, Kowloon, Hong Kong · 1 investments in Hong Kong Biotech startups

The International Medical is an investment firm

Show more...

Investment focus

  • Industry: Medical, Hospitality, Biotechnology
  • Stage:Seed
  • Geography: Hong Kong

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • BioMed Technology Holdings — BioMed offer a comprehensive service that includes a range of sophisticated tests performed by professionals, together with an interpretation and recommendations for how to live a healthy life.
Show all investments...

Apis Partners
VC Fund · London, England, United Kingdom · 1 investments in Hong Kong Biotech startups

Apis Partners LLP backs growth financial services innovators who create transformative impact in their communities.

Show more...

Investment focus

  • Industry: Financial Services, Payments, FinTech
  • Stage:Private Equity, Series B
  • Geography: India, Singapore, South Africa

Investor stats

  • Total investments: 33
  • Round size: Series B $5.4M–$110M; Private Equity $5M–$120M
  • Lead/follow: 70% lead, 30% follow
  • Last fund: May invest from a new fund soon — raised $550M in 2019

Portfolio highlights

  • TymeBank — TymeBank is a fully black-owned and controlled investment company based in South Africa. It is an exclusively digital retail bank that aims to provide every South African accessible and affordable banking so that they can take part in, grow and benefit from the country’s economy.
  • Money View — Money View is an application that is able to track and organize expenses, bills, and account balances. It is able to derive finance information from SMSs.Money View enables its users to set and follow budgets, view their bank account balance, obtain reminders about bills, and spit bills with the other users. It also facilitates Savings+ andTaxSaver+ that allows its users to save money.Money View was founded in April 2014 by Sanjay Aggarwal and Puneet Agarwal. It is based in Bangalore, Karnataka.
  • Peach Payments — Get Peach as your Payment Gateway and Grow your ecommerce. Process online payments with Visa, Mastercard, Debit Orders, EFT payments, and subscriptions. Plugins for Wix, Shopify, WooCommerce.
Show all investments...

Merrill Lynch
VC Fund · New York, New York, United States · 1 investments in Hong Kong Biotech startups

Merrill Lynch Wealth Management has the financial advisors and expertise to help you achieve your goals at any stage of your life or career.

Show more...

Investment focus

  • Industry: Software, Information Technology, Internet
  • Stage:Series B, Series C
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 88
  • Round size: Series B $10M–$80M; Series C $10M–$85M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • ITM Power — ITM Power manufacture PEM electrolysers. A pioneering technology that generates green hydrogen enabling customers to decarbonise.
  • Pharmacierge — Pharmacierge is the digital e-prescribing service chosen by private clinicians to deliver medication to their patients throughout the UK and worldwide. Clinicians create and transfer e-prescriptions to our pharmacy near London's Harley Street, for free delivery to their patients either the same day or next weekday
  • The Boeing Company — The Boeing Company is an American multinational corporation that designs, manufactures and sells fixed-wing aircraft, rotorcraft, rockets and satellites and provides leasing and product support services. Boeing is among the largest global aircraft manufacturers, is the second-largest aerospace & defense contractor in the world based on 2012revenue and is the US' largest exporter by dollar value. Boeing stock is a component of the Dow Jones Industrial Average.The Boeing Company's corporate headquarters are located in Chicago and the company is led by Chairman and CEO James McNerney. Boeing is organized into five primary divisions: Boeing Commercial Airplanes (BCA), Boeing Defense, Space & Security (BDS), Engineering, Operations & Technology, Boeing Capital and Boeing Shared Services Group.Boeing is the world's largest aerospace company and leading manufacturer of commercial jetliners and defense, space and security systems. A top U.S. exporter, the company supports airlines and U.S. and allied government customers in 150 countries. Boeing products and tailored services include commercial and military aircraft, satellites, weapons, electronic and defense systems, launch systems, advanced information and communication systems, and performance-based logistics and training.Boeing has a long tradition of aerospace leadership and innovation. The company continues to expand its product line and services to meet emerging customer needs. Its broad range of capabilities includes creating new, more efficient members of its commercial airplane family; integrating military platforms, defense systems and the warfighter through network-enabled solutions; creating advanced technology solutions; and arranging innovative customer-financing options.With corporate offices in Chicago, Boeing employs more than 170,000 people across the United States and in 70 countries. This represents one of the most diverse, talented and innovative workforces anywhere. More than 140,000 employees hold college degrees -- including nearly 35,000 advanced degrees -- in virtually every business and technical field from approximately 2,700 colleges and universities worldwide. Our enterprise also leverages the talents of hundreds of thousands more skilled people working for Boeing suppliers worldwide.Boeing is organized into two business units: Boeing Commercial Airplanes and Boeing Defense, Space & Security. Supporting these units are Boeing Capital Corporation, a global provider of financing solutions; the Shared Services Group, which provides a broad range of services to Boeing worldwide; and Boeing Engineering, Operations & Technology, which helps develop, acquire, apply and protect innovative technologies and processes.Divisions:- - - - -
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Ping An
VC Fund · Shenzhen, Guangdong, China · 1 investments in Hong Kong Biotech startups

Ping An Insurance Company is a holding company deals with insurance, banking, and financial service.

Show more...

Investment focus

  • Industry: Health Care, FinTech, Finance
  • Stage:Series A, Series E
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 26
  • Round size: Series A $1.4M–$300M; Series E $6.9M–$200M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Lixiangjia — The professional global Chinese overseas asset reconfiguration consulting service platform is dedicated to providing one-stop overseas asset product information support services for Chinese wealth management practitioners. It has set up branches in many cities across the country to provide institutions, financial planners and medium and high networth families. Professional overseas asset reconfiguration plan.
  • Biren Technology — Biren Technology is a high-tech startup that has the niche in softwares, hardwares, and chip system.The niche software department is led by the industry's top talents, composed of field technical experts and software elite engineers. The niche hardware department is committed to building a wide range of computing solutions based on generalcomputing, combining versatility and specificity.As a frontier research department of the niches, the Institute aims to study the key technologies of new intelligent computing systems, focusing on new architectures and advanced compilation technologies.
  • Lenovo Healthcare Information Technology (Lenovo HIT) — Lenovo Healthcare is a cloud-based smart medical solution company for medical institutions.
Show all investments...

208 Seed Ventures
VC Fund · Columbia, Missouri, United States · 1 investments in Hong Kong Biotech startups

208 Seed Ventures provides early-stage investments in frontier technologies. 2SV brings Midwestern leaders, investors, and operators together and invests in startups pushing current technological limits. Their network provides smart capital and resources for companies with big ideas to accelerate growth.

Show more...

Investment focus

  • Industry: Biotechnology
  • Stage:Seed
  • Geography: Hong Kong

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Avant Meats — They focus on technology, commercial product innovation, and branding as well as intellectual property portfolio building in the area of ‘cell-based’ animal protein food products.
Show all investments...

Particle Accelerator Limited (ParticleX)
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Biotech startups

Particle Accelerator Limited (ParticleX) was founded in late 2017 by Shine Works. ParticleX is a tech-based startup investor and accelerator based in Hong Kong. ParticleX combines network, capital and research resources, accelerating the pace of innovative technology and helping the early-stage startups to win cross-border opportunities acrossAsia.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Hong Kong, United States, Singapore

Investor stats

  • Total investments: 21
  • Round size: Seed $1.2M–$5.5M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Homeppl — Homeppl reveals consumer's real transactional ability. We leverage open banking, risk and financial algorithms, and unique fraud detection tests to allow consumers inclusive financial access to all financial or risk products in the world.Clients use Homeppl to increase revenue, prevent fraud, and eliminate transactional friction. Homepplhas reviewed hundreds of thousands of transactions and approved millions of pounds of revenue for clients in the UK.We are a Techstars company. Our team is comprised of ambitious, international, and passionate individuals. We are from 24 nationalities and speak over 17 languages!
  • Finquest — Finquest is the premier deal origination provider delivering personalized connections to its clients who seek M&A and direct investment opportunities in Europe, North America, and APAC.With a unique database, machine learning and a team of experts, Finquest provides targeted, curated and actionable connections, whilst maintaining completeconfidentiality throughout the process. With Finquest, clients can broaden their market access, creating a more efficient deal-making environment.Finquest is headquartered in Singapore and has offices in New York, London, Paris, Frankfurt, Luxembourg, Bangalore, and Hong Kong.
  • Crown Digital — Crown Digital harnesses the future-ready power of robotics and Artificial Intelligence to open doors with cutting-edge solutions for the not-so-distant future.
Show all investments...

Human Longevity and Performance Impact Venture Fund
VC Fund · 1 investments in Hong Kong Biotech startups

Human Longevity and Performance Impact Venture Fund is a longevity focused early-stage venture capital fund dedicated to providing resources, insight, and leadership to companies whose mission is to improve human health and drive longevity through technology, predictive analytics, research, and patient care. HLPIVF is establishing a synergisticecosystem of longevity and performance-focused companies to dramatically increase the volume and effectiveness of life-affirming diagnostics and therapeutics.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology
  • Stage:Series A
  • Geography: Hong Kong

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Deep Longevity — Deep Longevity provides customers with the most efficient, reliable, and useful aging and longevity clocks to address their needs.
Show all investments...

ETP Ventures
VC Fund · 1 investments in Hong Kong Biotech startups

ETP Ventures

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Angel, Series A
  • Geography: China, Hong Kong

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • SEIMEI — SEIMEI is a nutrition and anti-aging biotechnology brand.
  • Dima Biotech — Dima Biotech is a tumor immunotherapy and monoclonal antibody developer, specializing in the development of recombinant monoclonal antibodies for tumor immune products and services. It has the unique RECmAb digital monoclonal antibody technology, which can be used to obtain a variety of genus and high quality. Monoclonal antibodies.
  • Deep Longevity — Deep Longevity provides customers with the most efficient, reliable, and useful aging and longevity clocks to address their needs.
Show all investments...

Gobi Partners
VC Fund · Kuala Lumpur, Kuala Lumpur, Malaysia · 1 investments in Hong Kong Biotech startups, 17 in the past 12 months

Gobi Partners is the most interconnected Pan-Asian venture capital firm with US$1.5 billion in assets under management (AUM). Headquartered in Kuala Lumpur and Hong Kong, the firm supports entrepreneurs from the early to growth stages and focuses on emerging and underserved markets.Founded in 2002, Gobi has raised 15 funds to date, invested inover 350 startups and nurtured 10 unicorns. Gobi has grown to 15 locations across key markets in Bangkok, Beijing, Cairo, Guangzhou, Ho Chi Minh City, Hong Kong, Jakarta, Karachi, Kuala Lumpur, Lahore, Manila, Shanghai, Shenzhen, Singapore and Surabaya.As a Participant of the United Nations Global Compact, Gobi Partners is committed to aligning strategies and operations with universal principles on human rights, labour, environment and anti-corruption to ensure long-term value creation and sustainability across our portfolio.

Show more...

Investment focus

  • Industry: E-Commerce, Financial Services, Internet
  • Stage:Series A, Seed, Series B
  • Geography: China, Malaysia, Indonesia

Investor stats

  • Total investments: 147
  • Round size: Seed $687k–$8M; Series A $1.5M–$15M; Series B $2.7M–$30M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • CompAsia — Device lifecycle solutions for a greener world.
  • Kiddocare — They are on a journey to create an ecosystem to support working parents – giving them the gift of freedom and time by connecting them with babysitters to care for their children. It is also their aim to empower women who want to pursue childcare as a career or to generate extra income by giving them the platform to do so.
  • CAS Linkfiber — CAS Linkfiber is concentrating on key material technology research and manufacturing for hydrogen fuel cells, overcoming foreign suppliers' monopolies and attaining key material localization.
Show all investments...

AEF Greater Bay Area Fund
VC Fund · 1 investments in Hong Kong Biotech startups

AEF Greater Bay Area Fund is an investment fund.

Show more...

Investment focus

  • Industry: FinTech, Payments, Biopharma
  • Stage:Series A, Series B
  • Geography: Hong Kong

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • ChaZence — ChaZence is an environmental consulting and biotechnology company that manufactures, innovates, and designs naturally degradable materials for a sustainable lifestyle.
  • Scolioscan — Scolioscan focuses on medical imaging technology research & development, self-service production and technology distribution and promotion.
  • Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Show all investments...

Hillhouse Capital Group
VC Fund · Changyang, Beijing, China · 1 investments in Hong Kong Biotech startups, 23 in the past 12 months

Hillhouse Capital Group is an investment management firm that invests with a long-term time horizon. Hillhouse owns companies across equity stages, spanning the range from new start-ups to the world’s most established public companies. It may invest in a company as a start-up and continue to hold it in the portfolio as a public equity investment.This stage-agnostic investment style allows them to focus on multi-year results, rather than on quarterly earnings.Hillhouse Capital Group invests globally, with a particular focus on Asia. Independent, proprietary research lies at the heart of our investment process. Our team members are sector experts in consumer, Internet, media, and healthcare. Hillhouse Capital Group was founded in 2005 and is based in Beijing, China.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 309
  • Round size: Series A $1.4M–$120M; Series B $14M–$230M; Series C $14M–$310M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Immorna — Immorna specializes in the production of RNA-based therapeutics.
  • Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
  • Deep Vision Intelligence — Deep Vision Intelligence is a developer of embedded machine vision products.
Show all investments...

StartUp Health
VC Fund · New York, New York, United States · 1 investments in Hong Kong Biotech startups, 12 in the past 12 months

Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots

Show more...

Investment focus

  • Industry: Health Care, Wellness, Medical
  • Stage:Seed, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 140
  • Round size: Seed $100k–$2.5M; Pre-Seed $20k–$800k
  • Lead/follow: 4% lead, 96% follow
  • Last fund: May invest from a new fund soon — raised $31M in 2018

Portfolio highlights

  • AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
  • Medwise.ai — Medwise.ai is the Google for doctors.
  • Pear Suite — Pear Suite enables anyone—community health workers, other healthcare staff, and volunteers—to assess and address the social drivers of health for older adults in a scalable, cost-effective, and person-centered way.
Show all investments...

Longevity Vision Fund
VC Fund · New York, New York, United States · 1 investments in Hong Kong Biotech startups

Longevity Vision Fund is a $100M investment fund dedicated to making longevity affordable and accessible to all. The fund accelerates longevity breakthroughs by investing in companies that develop technologies, products, and services that extend healthy human lifespans and overcome the negative effects of agingLongevity Vision Fund provides Seedto Series C funding to biotech and life extension-focused companies that have demonstrated affordable longevity potential and vision of milestones driving up the value of the company and market validation.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series C, Seed
  • Geography: United States, Hong Kong, Isle of Man

Investor stats

  • Total investments: 13
  • Round size: Series B $35M–$440M; Series C $75M–$300M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Laronde — Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body. It is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery.Laronde was founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering. The company is rapidlyscaling to support the parallel development of multiple programs across many disease areas.
  • Exo — Exo is a medical device startup handheld ultrasound platform and AI for imaging and therapeutic applications. The company is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high-quality medical imaging. Exo empowers healthcare professionals to make critical,real-time decisions that improve patient outcomes.The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing, and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging. It also represents a giant leap in imaging and therapeutics technology one that will drive the development of high-performance products that are accessible, easy-to-use, and available at a price point never before possible.
  • Senda Biosciences — Senda Biosciences is pioneering the field of Intersystems Biology to create novel treatments for human disease. Intersystems Biology focuses on how molecular connections between botanical, bacterial, and human cells—coevolved over millennia—define health and disease. Senda's Intersytems Biology discovery platform, built using new techniques inmachine learning and computational biology, has been able to generate novel, actionable insights into the trillions of interspecies molecular connections in the human body, and harnesses the power of this "pharmacy within us" with novel pharmacological approaches. The power of the Senda platform is illustrated by six preclinical programs in oncology, neurology, chronic disease, and metabolic disease.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Capital Union Investments
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Biotech startups

Capital Union Investments is a leader in private investment for early stage, growth, mezzanine, and pre-IPO capital. Headquartered in Hong Kong; and with offices in China and the US, the Firm's investment philosophy has been to create value by identifying leaders and innovators, whose businesses that can be developed in Asia. Our approach ofproviding unique investment insights, local knowledge and value-added operating capabilities, differentiates us from many traditional private investment funds.

Show more...

Investment focus

  • Industry: SaaS, Genetics, Software
  • Stage:Seed, Series A
  • Geography: Hong Kong, United States

Investor stats

  • Total investments: 3
  • Round size: Seed $2M–$10M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bringhub — Bringhub is a contextual marketing platform that enables digital media and marketers to drive product discovery and sales. We have developed the most comprehensive contextual analysis and optimization engine on the market. We call it Sweeten.
  • Prenetics — CircleDNA is an at-home, non-invasive DNA test providing health insights across 500+ reports based on your unique genetic blueprint.
  • Dash Living — Dash Living is the new generation of serviced living solutions in Asia Pacific. Offering 2,000+ furnished rooms for rent, including coliving homes, serviced apartments, hotel rooms etc.
Show all investments...

Formic Ventures
VC Fund · San Francisco, California, United States · 1 investments in Hong Kong Biotech startups

Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups focused on human longevity as well as technology startups and companies that make human lives more meaningful.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Hong Kong

Investor stats

  • Total investments: 33
  • Round size: Seed $1.3M–$5M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Turn.bio — Turn Biotechnologies is a Stanford spinout developing therapies to effectively return mature differentiated cells to a dramatically younger state leaving their differentiated identity unaltered.​Turn Biotechnologies surpasses traditional approaches based on single gene/pathway manipulations and tackles the multifaceted manifestation ofcellular age at the organ, tissue, and organismal level to extend the healthspan of people. As a result, age is reset by epigenetically reprogramming cells.
  • cheMastery — Laboratory Automation
  • Sampling Human — On a mission to elevate societal health with living diagnostics that detect disease and measure effects of lifestyle choices at the single cell level.
Show all investments...

WI Harper Group
VC Fund · San Francisco, California, United States · 1 investments in Hong Kong Biotech startups

WI Harper Group is a venture capital firm that focuses on early and early expansion investments in Mainland China, Taiwan and Silicon Valley.It was founded in 1993. Made 300+ investments with 80+ exits. Manages 9 funds and over $1B in capital through 19 dedicated investment professionals located in Beijing, Taipei and San Francisco.Thefirm's focus is technology, clean technology and healthcare. Its track record includes

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: United States, Taiwan, China

Investor stats

  • Total investments: 138
  • Round size: Seed $1.4M–$5M; Series A $1.4M–$15M; Series B $5.9M–$25M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — raised $174M in 2016

Portfolio highlights

  • Bitmark — Bitmark restores trust in data. Our end-to-end Internet protocol secures the provenance of data. This makes it possible to have verifiable information, digital property rights, and safe sharing of personal data—without the need for trusted third parties. UC Berkeley, Pfizer, and KKBOX use Bitmark in healthcare, music, art, and more. #digitalrights
  • Blackpanda — Asia's premier digital forensics and cyber incident response firm.
  • FlexCompute — Our aerodynamics & electromagnetic simulation solutions reduce solve times, time to market, overall cost, and ensure a more robust product.
Show all investments...

China Venture Capital
VC Fund · Beijing, Beijing, China · 1 investments in Hong Kong Biotech startups

China Venture Capital is a venture capital industry trade group.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Information Technology
  • Stage:Angel, Series B, Series A
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 41
  • Round size: Angel $412k–$412k; Series A $1.4M–$14M; Series B $2.7M–$2.7M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Yihe Smart — Yihe Smart is a genetics-focused research and development firm.
  • Honest — Honest is a manufacturer of advanced equipment for mineral processing that specializes in developing X-ray-related electrical devices and system solutions.
  • Yanming Biology — Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors.
Show all investments...

AngelHub
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Biotech startups

Hong Kong's first SFC licensed startup investment platform for professional investors and global startups raising growth capital

Show more...

Investment focus

  • Industry: FinTech, Blockchain, Financial Services
  • Stage:Series A, Seed, Pre-Seed
  • Geography: Hong Kong, United States, Israel

Investor stats

  • Total investments: 16
  • Round size: Seed $1.1M–$4.8M; Pre-Seed $2M–$2.3M; Series A $3M–$4M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • NeoSwap — NeoSwap is a multi-party, multi-item NFT swap platform that redistributes items in a win-win-win manner, using minimal currency. It provides neo-barter solutions to unlock value within existing marketplaces and enable marketplaces where they were previously unsustainable. It was founded by John Ennis.
  • Antiverse — Designing biologics for 100 challenging targets
  • Klang Games — Klang Games is an entertainment & game development studio in Berlin, developing the MMO Simulation and Virtual World, Seed. Klang is always hiring!
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech VC Funds in Hong Kong investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in Hong Kong Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists